SCHEMBL21881792

SCHEMBL21881792

c1ccc(-c2ncnc(-c3ccc(-c4cc(-c5ccccc5)c(-c5ccccc5)c(-c5ccccc5)c4-c4ccccc4)cc3)n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
HPGD P15428 3/20 0.41
MAPT P10636 3/20 0.41
ALDH1A1 P00352 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.38
NTSR1 P30989 1/20 0.37
GPR55 Q9Y2T6 1/20 0.36
KDM4E B2RXH2 3/20 0.36
LMNA P02545 1/20 0.36
GLA P06280 1/20 0.36
NPC1 O15118 3/20 0.35
RAB9A P51151 3/20 0.35
MAPK1 P28482 1/20 0.35
POLB P06746 3/20 0.35
PPARG P37231 1/20 0.35
MCL1 Q07820 1/20 0.35
NR2E3 Q9Y5X4 1/20 0.35
NCOR2 Q9Y618 1/20 0.35
CYP1A2 P05177 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21881793 0.92 L3MBTL1 (0.35) MEN1KMT2AHPGDMAPTALDH1A1
SCHEMBL21881790 0.90 GP6 (0.35) MEN1KMT2AHPGDMAPTALDH1A1
SCHEMBL22722744 0.89 MEN1 (0.50) MEN1KMT2AHPGDMAPTALDH1A1
SCHEMBL21065686 0.87 MEN1 (0.48) MEN1KMT2AHPGDMAPTALDH1A1
SCHEMBL22722745 0.87 MEN1 (0.48) MEN1KMT2AHPGDMAPTALDH1A1
SCHEMBL22213077 0.83 L3MBTL1 (0.47) MEN1KMT2AHPGDMAPTALDH1A1
SCHEMBL25603540 0.83 HTT (0.30) MEN1KMT2AHPGDMAPTALDH1A1
SCHEMBL22722796 0.82 MEN1 (0.44) MEN1KMT2AHPGDMAPTALDH1A1
SCHEMBL18180830 0.82 MEN1 (0.44) MEN1KMT2AHPGDMAPTALDH1A1
SCHEMBL22722795 0.82 MEN1 (0.44) MEN1KMT2AHPGDMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11795186-B2 Organic electronic device comprising an organic semiconductor layer and a device NOVALED GMBH (DE) 2023-10-24 US disclosed
US-11795186-B2 Organic electronic device comprising an organic semiconductor layer and a device NOVALED GMBH (DE) 2023-10-24 US disclosed
US-20200161559-A1 Organic Electronic Device Comprising an Organic Semiconductor Layer NOVALED GMBH (DE) 2020-05-21 US disclosed
US-20200095269-A1 Organic Electronic Device Comprising an Organic Semiconductor Layer and a Device NOVALED GMBH (DE) 2020-03-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200095269-A1 Organic Electronic Device Comprising an Organic Semiconductor Layer and a Device C1S, C1R, CCNA1 MEN1 762/4885KMT2A 3297/4885HPGD 4229/4885
US-11795186-B2 Organic electronic device comprising an organic semiconductor layer and a device C1S, C1R, CCNA1 MEN1 762/4885KMT2A 3297/4885HPGD 4229/4885
US-20200161559-A1 Organic Electronic Device Comprising an Organic Semiconductor Layer C1S, YAP1, ESR1 MEN1 715/4885KMT2A 2561/4885HPGD 4294/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.